Abstract
The physiologic changes that constitute the process of sepsis are induced by microbial agents during bloodstream infection or by the toxic products of pathogens that are released from sites of focal infection. This process involves changes generated by the immune system and controlled by hormones, cytokines and enzymes. There are many host and microbial factors that may unfavorably influence this complex immune response. Underlying diseases with immunosuppressive effects, surgery, state of nutrition, immunomodulatory therapy and site of infection increase the risk for development of invasive disease and determine the extent of the immune response [1–3]. However, sepsis in the pediatric population occurs very frequently in previously healthy children. Also, in comparison with adults, the sepsis is more overwhelming. Mortality is mainly confined to the first 48 h of the disease. In children vs adults, different pathogens are involved and the quality and quantity of the immune response depend on the age of the child. These differences are probably caused by developmental aspects of several organ systems and may have special consequences for management and therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Jafari HS, McCracken GHJ (1992) Sepsis and septic shock: a review for clinicians. Pediatr Infect Dis J 11(9):739–748
Bell LM, Baker MD, Beatty D, Taylor L (1992) Infections in severely traumatized children. J Pediatr Surg 27(11): 1394–1398
Ashkenazi S, Leibovici L, Samra Z, Konisberger H, Drucker M (1992) Risk factors for mortality due to bacteremia and fungemia in childhood. Clin Infect Dis 14(4): 949–951
Ferrieri P (1990) Neonatal susceptibility and immunity to major bacterial pathogens. Rev Infect Dis 12[Suppl 4]:S394–S400
Zangwill KM, Schuchat A, Wenger JD (1992) Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. MMWR CDC Surveill Summ 41(6): 25–32
Jacobs RF, Sowell MK, Moss MM, Fiser DH (1990) Septic shock in children: bacterial etiologies and temporal relationships. Pediatr Infect Dis J 9(3): 196–200
Pryor RW, Hinshaw LB (1989) Sepsis/septic shock in adults and children. Pathol Immunopathol Res 8(5–6): 222–230
Brandtzaeg P, Kierulf P, Gaustad P, Skulberg A, Bruun JN, Halvorsen S, Sorensen E (1989) Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 159(2): 195–204
Bayston K, Cohen J (1990) Bacterial endotoxin and current concepts in the diagnosis and treatment of endotoxaemia. J Med Microbiol 31:73–83
Chesney P, Chesney R (1989) Hemorrhagic shock and encephalopathy: reflections about a new devastating disorder that affects normal children. J Pediatr 114(2): 254–256
Hellerqvist C, Sundell H, Gettins P (1987) Molecular basis for group B beta-hemolytic streptococcal disease. Proc Natl Acad Sci USA 84:51
Verheul AF, van Gaans JA, Wiertz EJ, Snippe H, Verhoef J, Poolman JT (1993) Meningococcal lipopolysaccharide (LPS)-derived oligosaccharide-protein conjugates evoke outer membrane protein but not LPS-specific bactericidal antibodies in mice: influence of adjuvants. Infect Immun 61(1): 187–196
Baldwin G, Alpert G, Caputo GL et al (1991) Effect of polymyxin B on experimental shock from meningococcal and Escherichia coli endotoxins. J Infect Dis 164(3): 542–549
Verheul A, Snippe H, Poolman J (1993) Meningococcal lipopolysaccharides: virulence factor and potential vaccine component. Microbiol Rev 57(1): 34–49
Poolman JT (1988) Meningococcal vaccines. J Med Microbiol 26(3): 170–172
Cairo MS (1989) Neonatal neutrophil host defense. Prospects for immunologic enhancement during neonatal sepsis. Am J Dis Child 143(1): 40–46
English BK, Burchett SK, English JD, Ammann AJ, Wara DW, Wilson CB (1988) Production of lymphotoxin and tumor necrosis factor by human neonatal mononuclear cells. Pediatr Res 24(6): 717–722
Cairo M (1991) Cytokines: a new Immunotherapy. Clin Perinatol 18(2): 343–359
Wei C, Gilliam M, Cohen M, Cornell J, Moazam F (1987) A preliminary study of age-related difference in resistance to sepsis in the rat model. J Surg Res 43:460–467
Zamir O, Hasseigren PO, Frederick JA, Fischer JE (1992) Is the metabolic response to sepsis in skeletal muscle different in infants and adults? An experimental study in rats. J Pediatr Surg 27(11): 1399–1403
Pedersen PV, Warner BW, Bjornson HS et al (1989) Hemodynamic and metabolic alterations during experimental sepsis in young and adult rats. Surg Gynecol Obstet 168(2): 148–156
Fitzgerald MJ, Goto M, Myers TF, Zeller WP (1992) Early metabolic effects of sepsis in the preterm infant: lactic acidosis and increased glucose requirement. J Pediatr 121(6): 951–955
Zeller WP, Goto M, Hurley RM (1988) Endotoxin in newborn septic shock: significance, metabolic, and cardiovascular changes. Ann Clin Lab Sci 18(3): 253–259
Horton JW, Coln D (1985) Cardiovascular function and fluid compartments in newborn canine hemorrhagic shock. Am J Physiol 248(6, 2):R724–R731
Agata Y, Hiraishi S, Oguchi K et al (1991) Changes in left ventricular output from fetal to early neonatal life (see comments). J Pediatr 119(3): 441–445
Fiser DH, Fewell JE, Hill DE, Brown AL (1988) Cardiovascular and renal effects of dopamine and dobutamine in healthy, conscious piglets. Crit Care Med 16(4): 340–345
Shavit G, Sagy M, Nadler E, Vidne BA, Gitter S (1989) Myocardial response to alpha-agonist (phenylephrine) in relation to age. Crit Care Med 17(12): 1324–1327
Monsalve F, Rucabado L, Salvador A, Bonastre J, Cuñat J, Ruano M (1984) Myocardial depression in septic shock caused by meningococcal infection. Crit Care Med 12(12): 1021–1023
Boucek MM, Boerth RC, Artman M, Graham TP, Boucek RJ (1984) Myocardial dysfunction in children with acute meningococcemia. J Pediatr 105:538–542
Mercier J-C, Beaufils F, Hartmann J-F, Azéma D (1988) Hemodynamic patterns of meningococcal shock in children. Crit Care Med 16(1): 27–33
Carcillo JA, Davis AL, Zaritsky A (1991) Role of early fluid resuscitation in pediatric septic shock. JAMA 266(9): 1242–1245
Carcillo JA, Pollack MM, Ruttimann UE, Fields AI (1989) Sequential physiologic interactions in pediatric cardiogenic and septic shock. Crit Care Med 17(1): 12–16
van Teunenbroek A, Peters M, Sturk A, Borm JJ, Breederveld C (1990) Protein C activity and antigen levels in childhood. Eur J Pediatr 149(11): 774–778
Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, Powers P (1987) Development of the human coagulation system in the full-term infant. Blood 70(1): 165–172
Leclerc F, Hazelzet J, Jude B, Hofhuis W, Hue V, Martinot A, van der Voort E (1992) Protein C and S deficiency in severe infectious purpura of children: a collaborative study of 40 cases. Intensive Care Med 18(4): 202–205
Taylor FBJ, Chang A, Esmon CT, D’Angelo A, Vigano-D’Angelo S, Blick KE (1987) Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest 79(3): 918–925
Busund R, Lindsetmo R, Balteskard L, Rekvig O, Revhaug A (1993) Repeated plasma therapy induces fatal shock in experimental septicemia. Circ Shock 40:268–275
Heyderman RS, Klein NJ, Shennan GI, Levin M (1991) Deficiency of prostacyclin production in meningococcal shock. Arch Dis Child 66(11): 1296–1299
Gill AB, Weindling AM (1993) Echocardiographic assessment of cardiac function in shocked very low birthweight infants. Arch Dis Child 68[Suppl 1]: 17–21
Waage A, Halstensen A, Shalaby R, Brandtzaeg P, Kierulf P, Espevik T (1989) Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response. J Exp Med 170(6): 1859–1867
Waage A, Brandtzaeg P, Halstensen A, Kierulf P, Espevik T (1989) The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med 169(1): 333–338
Saladino R, Erikson M, Levy N, Bachman D, Silber GR, Fleisher GR (1992) Utility of serum interleukin-6 for diagnosis of invasive bacterial disease in children. Ann Emerg Med 21(12): 1413–1417
Sullivan JS, Kilpatrick L, Costarino ATJ, Lee SC, Harris MC (1992) Correlation of plasma cytokine elevations with mortality rate in children with sepsis. J Pediatr 120(4,1): 510–515
Hazelzet JA, van den Voort E, Lindemans J, ter Heerdt PGJ, Neyens HJ (1993) Relation between cytokines and routine laboratory parameters in children with septic shock and purpurae. Intensive Care Med (in press)
Halstensen A, Ceska M, Brandtzaeg P, Redl H, Naess A, Waage A (1993) Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease. J Infect Dis 167(2): 471–475
Brandtzaeg P, Joo GB, Brusletto B, Kierulf P (1990) Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease. Thromb Res 57(2): 271–278
Kuster H, Degitz K (1993) Circulating ICAM-1 in neonatal sepsis (letter). Lancet 341(8843):506
Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C (1993) High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341(8844): 515–518
Speer CP, Rethwilm N, Gahr M (1987) Elastase-α1-proteinase inhibitor: an early indicator of septicaemia and bacterial meningitis in children. J Pediatr 111:667–671
Tegtmeyer FK, Horn C, Richter A, van Wees J (1992) Elastase alpha 1 proteinase inhibitor complex, granulocyte count, ratio of immature to total granulocyte count, and C-reactive protein in neonatal septicaemia. Eur J Pediatr 151(5): 353–356
Leclerc F, Chenaud M, Delepoulle F, Francois DJ, Alain M, Valerie H (1991) Prognostic value of C-reactive protein level in severe infectious purpura: a comparison with eight other scores. Crit Care Med 19(3): 430–432
Housinger TA, Brinkerhoff C, Warden GD (1993) The relationship between platelet count, sepsis, and survival in pediatric burn patients. Arch Surg 128(1): 65–66
Pollack M, Ruttimann U, Getson P (1988) Pediatric risk of mortality (PRISM) score. Crit Care Med 16:1110–1116
Leclerc F, Beuscart R, Guillois B et al (1985) Prognostic factors of severe infectious purpura in children. Intensive Care Med 11(3): 140–143
Fischer GW (1988) Immunoglobulin therapy of neonatal group B streptococcal infections: an overview. Pediatr Infect Dis J 7[Suppl 5]:S13–S16
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hazelzet, J.A., de Groot, R. (1994). Sepsis-Related Problems in Pediatric Patients. In: Reinhart, K., Eyrich, K., Sprung, C. (eds) Sepsis. Update in Intensive Care and Emergency Medicine, vol 18. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85036-3_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-85036-3_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-85038-7
Online ISBN: 978-3-642-85036-3
eBook Packages: Springer Book Archive